Eli Lilly and Co on Tuesday aimed to ease investor concerns about its COVID-19 antibody treatment after a trial of the therapy failed to show a benefit in hospitalized patients.

Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

Non-inferiority trial versus PAXLOVID® assessing safety and efficacy, including rates of disease rebound and incidence of Long COVID development, of ratutrelvir, a ritonavir-free anti-viral treatment ...

Orland Park District 135 moved to hire assistant principals at Park School and Center School, where younger students attend.

Populations Insights for GEO-CM04S1 in Immunocompromised Patients ATLANTA, GA - October 9, 2025 (NEWMEDIAWIRE) - GeoVax Labs, ...

“These recent scientific reports strengthen the theory that Long COVID is, at least in part, sustained by a persistent viral reservoir,” said Dr. Ryan Saadi, Founder and CEO of Tevogen. “Our ...

(NASDAQ:MRNA) today announced that clinical, safety and translational data from its Phase 1/2 study evaluating mRNA-4359 in ...

The partnership in science and technology (S&T) is strong and can now pivot to take on new responsibilities for sustainable ...

PsychologyCare, a clinical psychology practice based in Melbourne, is drawing attention to the use of integrative psychotherapy and schema therapy for individuals facing complex mental health ...

The 43rd District Rep said it’s a chance for “community members to gather, get loud, and voice their support for progressive ...